Clinical Trial Detail

NCT ID NCT01187810
Title Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

non-Hodgkin lymphoma

Therapies

Fenretinide

Cytarabine

Methotrexate

Age Groups: child

No variant requirements are available.